Ignite Creation Date:
2025-12-24 @ 11:49 PM
Ignite Modification Date:
2026-01-02 @ 5:28 AM
Study NCT ID:
NCT00363051
Status:
COMPLETED
Last Update Posted:
2013-05-10
First Post:
2006-08-02
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety/Efficacy of Everolimus in Adults With Advanced Pancreatic Neuroendocrine Cancer Not Responsive to Chemotherapy
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-06
Start Date Type:
None
Primary Completion Date:
2008-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-04
Completion Date Type:
ACTUAL
First Submit Date:
2006-08-02
First Submit QC Date:
None
Study First Post Date:
2006-08-15
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2011-12-02
Results First Submit QC Date:
None
Results First Post Date:
2012-03-30
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-05-06
Last Update Post Date:
2013-05-10
Last Update Post Date Type:
ESTIMATED